Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/153798
Full metadata record
DC FieldValueLanguage
dc.creatorQuispe, C
dc.creatorMartins, N
dc.creatorManca, ML
dc.creatorManconi, M
dc.creatorSytar, O
dc.creatorHudz, N
dc.creatorShanaida, M
dc.creatorKumar, M
dc.creatorTaheri, Y
dc.creatorMartorell, M
dc.creatorSharifi-Rad, J
dc.creatorPintus, G
dc.creatorCho, WC
dc.date.accessioned2023-11-08T09:57:49Z-
dc.date.available2023-11-08T09:57:49Z-
dc.date.issued2021
dc.identifier.issn1942-0900
dc.identifier.urihttps://hdl.handle.net/10216/153798-
dc.description.abstractDue to its vast therapeutic potential, the plant-derived polyphenol curcumin is utilized in an ever-growing number of health-related applications. Here, we report the extraction methodologies, therapeutic properties, advantages and disadvantages linked to curcumin employment, and the new strategies addressed to improve its effectiveness by employing advanced nanocarriers. The emerging nanotechnology applications used to enhance CUR bioavailability and its targeted delivery in specific pathological conditions are collected and discussed. In particular, new aspects concerning the main strategic nanocarriers employed for treating inflammation and oxidative stress-related diseases are reported and discussed, with specific emphasis on those topically employed in conditions such as wounds, arthritis, or psoriasis and others used in pathologies such as bowel (colitis), neurodegenerative (Alzheimer's or dementia), cardiovascular (atherosclerosis), and lung (asthma and chronic obstructive pulmonary disease) diseases. A brief overview of the relevant clinical trials is also included. We believe the review can provide the readers with an overview of the nanostrategies currently employed to improve CUR therapeutic applications in the highlighted pathological conditions.
dc.description.sponsorshipN.C.-M. acknowledges the Portuguese Foundation for Science and Technology under the Horizon 2020 Program (PTDC/PSI-GER/28076/2017). This work was supported by the CONICYT PIA/APOYO CCTE AFB170007, Seed #2001050151 and Collaborative #2101050160—University of Sharjah and Fondo di Ateneo per la Ricerca 2020, University of Sassari.
dc.language.isoeng
dc.publisherHindawi
dc.relation.ispartofOxidative Medicine and Cellular Longevity, vol.2021:3149223
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.meshArthritis / drug therapy
dc.subject.meshArthritis / pathology
dc.subject.meshBiological Availability
dc.subject.meshCurcumin / chemistry
dc.subject.meshCurcumin / therapeutic use
dc.subject.meshDrug Carriers / chemistry
dc.subject.meshDrug Stability
dc.subject.meshHumans
dc.subject.meshNanotechnology
dc.subject.meshNeurodegenerative Diseases / drug therapy
dc.subject.meshNeurodegenerative Diseases / pathology
dc.subject.meshPlants, Medicinal / chemistry
dc.subject.meshPlants, Medicinal / metabolism
dc.titleNano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.1155/2021/3149223
dc.relation.publisherversionhttps://www.hindawi.com/journals/omcl/2021/3149223/
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.1155-2021-3149223.pdf1.27 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons